3-((5aS,5bS,7aS,10aS,10bR,12aS)-5a,7a-dimethyl-2,4,5,5a,5b,6,7,7a,10,10a,10b,11,12,12a-tetradecahydro-1H-cyclopenta[5,6]naphtho[1,2-d]oxepin-8-yl)-5-methylpyridine

ID: ALA3931417

PubChem CID: 68086702

Max Phase: Preclinical

Molecular Formula: C25H35NO

Molecular Weight: 365.56

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cncc(C2=CC[C@H]3[C@@H]4CC[C@H]5CCOCC[C@]5(C)[C@H]4CC[C@]23C)c1

Standard InChI:  InChI=1S/C25H35NO/c1-17-14-18(16-26-15-17)21-6-7-22-20-5-4-19-9-12-27-13-11-24(19,2)23(20)8-10-25(21,22)3/h6,14-16,19-20,22-23H,4-5,7-13H2,1-3H3/t19-,20-,22-,23-,24-,25+/m0/s1

Standard InChI Key:  NWEHUYRHAUYHKV-ABVATSDPSA-N

Molfile:  

     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   22.1670  -24.7184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9425  -25.5083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1751  -25.7844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1992  -26.6025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5032  -27.0356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5304  -27.8546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8395  -28.2846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1214  -27.8955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0923  -27.0847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7832  -26.6506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7560  -25.8357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4520  -25.4026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7832  -27.4698    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   18.4356  -26.5927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6459  -26.8054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3175  -27.5519    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6955  -28.2596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4941  -28.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0923  -26.2656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1214  -28.7147    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   20.5032  -26.2165    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   21.9850  -26.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4447  -26.1523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1992  -27.4174    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   21.2337  -24.9669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5980  -24.1283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8256  -23.3458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6185  -23.1452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1853  -23.7293    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9644  -24.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2459  -22.7662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  6  5  1  0
  7  6  1  0
  8  7  1  0
  9  8  1  0
  9 10  1  0
 11 10  1  0
 12 11  1  0
  3 12  1  0
  5 10  1  0
 10 13  1  6
  9 14  1  0
 15 14  1  0
 16 15  1  0
 17 16  1  0
 18 17  1  0
  8 18  1  0
  9 19  1  1
  8 20  1  6
  5 21  1  1
  4 22  1  0
 23 22  1  0
  2 23  2  0
  4 24  1  6
  3 25  1  1
 26  1  2  0
 27 26  1  0
 28 27  2  0
 29 28  1  0
 30 29  2  0
  1 30  1  0
 27 31  1  0
M  END

Associated Targets(Human)

Liver (3974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP17A1 Tclin Cytochrome P450 17A1 (3627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP21A2 Tchem Cytochrome P450 21 (835 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver (4264 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cyp11b2 Cytochrome P450 11B (409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 365.56Molecular Weight (Monoisotopic): 365.2719AlogP: 6.05#Rotatable Bonds: 1
Polar Surface Area: 22.12Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 5.32CX LogP: 5.02CX LogD: 5.02
Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.60Np Likeness Score: 1.39

References

1.  (2013)  C-17-heteroaryl steroidal compounds as inhibitors of CYP11B, CYP17, and/or CYP21, 

Source